ARCHIVES

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

Mammography Screening Effective In Women Under 50: BCDDP

September 25, 1987

Biomedical Panel Says Cancer Panel Should Expand to Serve all NIH

June 4, 1976

NCAB forms subcommittee to develop NCI biomedical technologies initiative.

September 26, 2003

Guest Editorial: The Supreme Court Decision on the ACA and What It Can Mean to Oncology

June 29, 2012

Men With Low PSA Scores May Not Need Annual Tests, Data From PLCO Trial Suggests

May 31, 2002